The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Cyklokapron 100 mg/mL solution for injection/infusion

Pfizer Healthcare IrelandPA0822/117/001

Main Information

Trade NameCyklokapron 100 mg/mL solution for injection/infusion
Active SubstancesTranexamic acid
Dosage FormSolution for injection/infusion
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/117/001

Group Information

ATC CodeB02AA Amino acids
B02AA02 tranexamic acid


License statusAuthorised
Licence Issued01/04/1983
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back